ABBOTT INDIA
|
ABBOTT INDIA Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 446.78 | 375.86 | 325.03 | 279.03 | 211.93 |
| CEPS(Rs) | 479.71 | 406.96 | 352.39 | 307.08 | 219.89 |
| DPS(Rs) | 325.00 | 275.00 | 275.00 | 250.00 | 65.00 |
| Book NAV/Share(Rs) | 1,480.48 | 1,306.18 | 1,203.71 | 1,127.50 | 932.19 |
| Tax Rate(%) | 25.47 | 26.03 | 25.41 | 26.13 | 35.56 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 21.96 | 21.51 | 20.56 | 18.47 | 16.42 |
| EBIT Margin(%) | 23.50 | 21.86 | 21.12 | 19.82 | 19.06 |
| Pre Tax Margin(%) | 23.20 | 21.48 | 20.71 | 19.61 | 19.00 |
| PAT Margin (%) | 17.29 | 15.89 | 15.45 | 14.49 | 12.24 |
| Cash Profit Margin (%) | 18.57 | 17.20 | 16.75 | 15.94 | 12.70 |
| Performance Ratios | |||||
| ROA(%) | 21.71 | 19.89 | 18.78 | 18.36 | 16.90 |
| ROE(%) | 32.07 | 29.95 | 27.89 | 27.09 | 24.66 |
| ROCE(%) | 42.93 | 40.53 | 37.52 | 36.54 | 37.88 |
| Asset Turnover(x) | 1.26 | 1.25 | 1.22 | 1.27 | 1.38 |
| Sales/Fixed Asset(x) | 12.46 | 13.12 | 13.04 | 16.07 | 25.48 |
| Working Capital/Sales(x) | 3.02 | 1.90 | 1.82 | 1.77 | 1.93 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.08 | 0.08 | 0.08 | 0.06 | 0.04 |
| Receivable days | 20.12 | 19.54 | 23.19 | 26.49 | 26.77 |
| Inventory Days | 44.44 | 51.02 | 50.82 | 50.56 | 59.14 |
| Payable days | 109.28 | 113.47 | 108.42 | 104.13 | 99.97 |
| Valuation Parameters | |||||
| PER(x) | 49.43 | 47.09 | 46.11 | 55.39 | 34.43 |
| PCE(x) | 46.04 | 43.49 | 42.53 | 50.33 | 33.18 |
| Price/Book(x) | 14.92 | 13.55 | 12.45 | 13.71 | 7.83 |
| Yield(%) | 1.47 | 1.55 | 1.83 | 1.62 | 0.89 |
| EV/Net Sales(x) | 8.41 | 7.10 | 6.83 | 7.49 | 3.76 |
| EV/Core EBITDA(x) | 33.09 | 29.93 | 29.37 | 35.19 | 19.25 |
| EV/EBIT(x) | 34.89 | 31.73 | 31.18 | 37.78 | 19.71 |
| EV/CE(x) | 9.91 | 8.29 | 7.70 | 8.68 | 4.72 |
| M Cap / Sales | 8.77 | 7.65 | 7.39 | 8.02 | 4.21 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 8.86 | 14.00 | 5.30 | 11.27 | 11.52 |
| Core EBITDA Growth(%) | 16.73 | 16.22 | 15.10 | 21.28 | 11.93 |
| EBIT Growth(%) | 17.38 | 16.37 | 16.39 | 15.71 | 12.12 |
| PAT Growth(%) | 18.87 | 15.64 | 16.49 | 31.67 | 12.24 |
| EPS Growth(%) | 18.87 | 15.64 | 16.49 | 31.66 | 12.24 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.51 | 3.20 | 3.38 | 3.60 | 3.22 |
| Quick Ratio(x) | 1.97 | 2.63 | 2.69 | 3.00 | 2.51 |
| Interest Cover(x) | 80.66 | 57.53 | 51.65 | 95.10 | 311.82 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹54,833.4 Cr | -1.5% | -4.5% | 13.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
| CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -1.5% |
-4.5% |
13.9% |
| SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses
